A detailed history of Royal Bank Of Canada transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 155,104 shares of CRL stock, worth $25.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
155,104
Previous 166,795 7.01%
Holding current value
$25.6 Million
Previous $32.9 Million 12.86%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$178.58 - $220.69 $2.09 Million - $2.58 Million
-11,691 Reduced 7.01%
155,104 $28.6 Million
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $1.66 Million - $2.17 Million
-8,854 Reduced 5.04%
166,795 $32.9 Million
Q2 2024

Nov 06, 2024

SELL
$206.39 - $268.73 $115,991 - $151,026
-562 Reduced 0.32%
175,649 $36.3 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $479,031 - $623,722
2,321 Added 1.33%
176,211 $36.4 Million
Q1 2024

Nov 05, 2024

SELL
$203.52 - $273.43 $586,748 - $788,298
-2,883 Reduced 1.64%
173,328 $47 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $1.98 Million - $2.66 Million
-9,714 Reduced 5.29%
173,890 $47.1 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $933,157 - $1.35 Million
-5,672 Reduced 3.0%
183,604 $43.4 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $188,995 - $211,516
972 Added 0.52%
189,276 $37.1 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $3.64 Million - $4.16 Million
19,796 Added 11.75%
188,304 $39.6 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $470,514 - $637,323
-2,452 Reduced 1.43%
168,508 $34 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $2.16 Million - $2.73 Million
-10,936 Reduced 6.01%
170,960 $37.2 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $107 Million - $146 Million
-584,417 Reduced 76.26%
181,896 $35.8 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $2.13 Million - $3.15 Million
-10,426 Reduced 1.34%
766,313 $164 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $13.1 Million - $18.5 Million
51,139 Added 7.05%
776,739 $221 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $2.21 Million - $2.83 Million
6,303 Added 0.88%
725,600 $273 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $4.86 Million - $5.97 Million
-13,037 Reduced 1.78%
719,297 $297 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $215 Million - $272 Million
732,334 New
732,334 $271 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.